Last reviewed · How we verify
NCT04561505
HoLEP vs mTURP in Management of Benign Prostatic Hyperplasia
NA trial testing Holmium laser enucleation of prostate in Prostatic Hyperplasia in 60 participants. Completed in 29 February 2020.
1 February 2020
Quick facts
| Lead sponsor | Ain Shams University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 60 |
| Start date | 1 February 2018 |
| Primary completion | 1 February 2020 |
| Estimated completion | 29 February 2020 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Holmium laser enucleation of prostate
- monopolar transurethral resection of prostate
Conditions studied
- Prostatic Hyperplasia — all drugs for Prostatic Hyperplasia →
Sponsor
Ain Shams University
Who can join
Eligibility, male only, with Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the clinical outcome regarding safety and efficacy between Holmium laser enucleation of the prostate and transurethral resection of the prostate in management of benign prostatic hyperplasia.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04561505
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Holmium laser enucleation of prostate
Trials testing the same drug.
- NCT06849089 — HoLEP: Learning Curve Analysis and Comparison With TURP · completed
Other recruiting trials for Prostatic Hyperplasia
Currently open trials in the same condition.
- NCT06242119 — Clinical Application of the J-PET Scanner Prototype · recruiting
- NCT06161506 — Surface Electrical Stimulation for Urinary Incontinence in Men Treated for Prostate Cancer · Phase 2 · recruiting
- NCT06209307 — Pelvic Floor Physical Therapy to Reduce Stress Urinary Incontinence After Holmium Laser Enucleation of the Prostate · NA · active not recruiting
- NCT06001619 — Prostate Medication, Metabolism and Gut Microbiota · Phase 4 · recruiting
- NCT03354416 — Profiling of Radiological Factors in Treatment and Outcomes in Prostate Cancer · recruiting
Other Ain Shams University trials
Trials by the same sponsor.
- NCT07435493 — Fentanyl Versus Opioid Free Multimodal Analgesia for Perioperative Pain Control in Children With Mild to Moderate Obstru · NA · not yet recruiting
- NCT07482540 — Role of Dexmedatomidine Drug in Prevention of Atrial Fibrillations Post Mitral Valve Surgery · NA · not yet recruiting
- NCT07531030 — Posterior Pericapsular Deep Gluteal Block Combined With Pericapsular Nerve Group and Lateral Femoral Cutaneous Nerve Blo · NA · not yet recruiting
- NCT06839027 — Arterial to Central co2gap in Relation to Outcome After Cardiopulmonary Bypass · not yet recruiting
- NCT07516535 — DISS vs FANS in Suction-Assisted RIRS for Medium-Sized Renal Stones · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04561505 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ain Shams University
- Last refreshed: 23 September 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04561505.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing